Prescription trends of disease-modifying treatments for multiple sclerosis in Iran over the past 30 years.
Ghadiri F, Sahraian MA, Baghbanian SM, Ashtari F, Razazian N, Majdinasab N, Poursadeghfard M, Hatamian H, Harirchian MH, Beladimoghadam N, Azimi A, Sharifipour E, Hosseini S, Bayati A, Kamali H, Hosseni Nejad Mir N, Faraji F, Mozhdehipanah H, Modara F, Navardi S, Heidari H, Ayoubi S, Naser Moghadasi A, Eskandarieh S.
Ghadiri F, et al. Among authors: beladimoghadam n.
Mult Scler Relat Disord. 2022 May;61:103777. doi: 10.1016/j.msard.2022.103777. Epub 2022 Mar 27.
Mult Scler Relat Disord. 2022.
PMID: 35390594